About this Event
“From Zero to Changing Spinal Surgery in Less Than 5 Years.”
It is our privilege to showcase, Carlsmed®, a startup that entered EvoNexus as a two-person team and built a company that survived challenging world events involving a pandemic, supply chain issues, inflation, high-interest rates, and a tough venture capital market.
Carlsmed recognized an unmet need in orthopedic surgery. The industry had relied on a surgical plan that had not been re-invented in decades and there had been no solutions to sufficiently addressed the continual complications and revision often seen in spinal surgeries. Carlsmed’s core belief was that they could significantly improve patient outcomes in spinal surgery. Mike Cordonnier will be sharing his first-had experience of his journey, including the ups and downs he faced, and where he sees Carlsmed positioning itself in the future of orthopedic surgery.
Our moderator is the attorney and law firm that has been representing Carlsmed almost ever since its inception and has been a partner throughout the journey of this startup. We recommend that you watch the below ABC10 News feature on Carlsmed before the program starts, so that you are up to speed on its technology and value proposition.
Moderator
Jim Krenn, Partner, Morrison & Foerster
Jim has extensive experience representing private and public companies and investors in significant business transactions from formation through liquidity. His practice focuses on mergers and acquisitions, venture capital financings, and emerging company counseling. His clients span a broad range of industries, with a concentration in life science and technology companies.
He also advises clients on private and public acquisitions on both the buy-side and sell-side across numerous transaction structures, including equity purchases, asset purchases, mergers, acquisitions, divestitures, cross-border transactions, and auctions. He has represented buyers and sellers in acquisitions and divestitures ranging from the low millions to over $1 billion.
Jim counsels emerging and established life sciences and technology companies in equity financings and general corporate matters, and angel, corporate, and venture capital investors in investments in such companies. He has represented clients in over $3 billion in equity and debt financings ranging from seed rounds to $100 million-plus later-stage rounds.
In addition, Jim represents public companies in public offerings, other capital markets transactions, and SEC reporting and compliance matters, and advises boards of directors on corporate governance issues.
Jim is member of the firm’s Life Sciences + Healthcare Group leadership team and Artificial Intelligence steering committee and serves on the Board of Directors of the San Diego Entrepreneurs Exchange.
Featured Speaker
Mike Cordonnier, Co-Founder & CEO, Carlsmed
Mike is the co-founder and serves as Chief Executive Officer and President of Carlsmed, he also serves as Chairman of the Board of Directors.
Mike has over two decades of experience successfully leading teams in introducing groundbreaking medical technologies. He possesses extensive operational expertise in both private and public companies, having contributed to the success of organizations such as NuVasive, Ellipse Technologies, Zimmer Biomet, Orchid Orthopedics, and X-Spine Systems.
Mike holds a Bachelor of Science degree in Mechanical Engineering from the University of Dayton.
ABOUT MORRISON FOERSTER
Morrison Foerster transforms complexity into advantage. With their collective intelligence, MoFo shapes powerful legal strategies that move your business forward while living shared values.
They solve your most critical multidimensional challenges in a way that provides clarity around the risk you are facing and gives you confidence in your chosen path. MoFo pairs diversity of perspective with a strategic consultative approach to craft the tailored strategies you need. They foster trusted partnerships that are defined by winning for you when it matters most.
Their clients include some of the largest financial institutions, Fortune 100 companies, and leading technology and life sciences companies. Whether established for decades or just an entrepreneur’s idea, MoFo represents organizations as they grow, innovate, disrupt, and develop into leading industry players and household names.
ABOUT EVONEXUS
EvoNexus is California’s leading nonprofit technology startup incubator located in San Diego. EvoNexus has successfully incubated over 260 startups with a survival rate of over 85%. Since the incubator’s formation in 2010, EvoNexus companies have secured over $1.6B in venture funding, $10B in pre-exit valuation, and had over 54 acquisitions valued at over $2.1B. YTD $240M invested. EvoNexus is supported by corporate partners, including some of the largest multinational corporations in the world such as Qualcomm, Viasat, muRata, pSemi, and more!
Event Venue & Nearby Stays
Morrison Foerster, 12531 High Bluff Drive, San Diego, United States
USD 0.00